Dopamine receptors are responsible for diverse effects within and outside the central nervous system. The five dopamine receptors that have been cloned (DIA, D1B also known as D5, D2, D3, and D4) belong to two major families; the D1 like and D2 like dopamine receptors. The D1 like receptors are linked to the stimulation while D2 like receptors are linked to the inhibition of adenylyl cyclase. The physiologic role of the dopamine receptors has been difficult to decipher because several of the subtypes co-exist in the same tissue. However, studies of receptors artificially expressed using transfected cDNA have revealed some of the biochemical mechanisms unique to each dopamine receptor subtype. (Hypertens Res 1995;18 Suppl. I: S19-S22) Key Words: dopamine receptor, transfected cell, receptor synergism Dopamine modulates many cellular activities including behavior, movement, hormone synthesis and release, blood pressure and transmembrane ion transport. Dopamine mediates its effects through dopamine receptors which are classified into two super families, the D1 and D2 subtypes, based on their interaction with effector enzymes. D1 receptors stimulate adenylyl cyclase via the stimulatory G protein Gs, whereas D2 receptors inhibit this enzyme via the inhibitory G protein (Gi). Besides the inhibition of adenylyl cyclase, D2 receptors have been shown to interact with other signaling pathways and effector proteins, including potassium channels, calcium channels, phosphatidylinositol metabolism and arachidonic acid release (1). D1 receptors, on the other hand, have been shown to stimulate phospholipase C independent of their effect on cAMP (2).
Dopamine modulates many cellular activities including behavior, movement, hormone synthesis and release, blood pressure and transmembrane ion transport. Dopamine mediates its effects through dopamine receptors which are classified into two super families, the D1 and D2 subtypes, based on their interaction with effector enzymes. D1 receptors stimulate adenylyl cyclase via the stimulatory G protein Gs, whereas D2 receptors inhibit this enzyme via the inhibitory G protein (Gi) . Besides the inhibition of adenylyl cyclase, D2 receptors have been shown to interact with other signaling pathways and effector proteins, including potassium channels, calcium channels, phosphatidylinositol metabolism and arachidonic acid release (1) . D1 receptors, on the other hand, have been shown to stimulate phospholipase C independent of their effect on cAMP (2).
Many dopamine receptor subtypes have been shown to coexist on the cell surface. Determining the role of individual receptor subtypes on physiologic function has been hampered by the lack of pharmacologic specificity of ligands and the modulation of one receptor by the presence of the other. Transfection studies have allowed the permanent expression of dopamine receptors in a wide variety of cell lines including the CHO (Chinese hamster ovary cells), GH4C1 (pituitary cells), LTK-(fibroblasts), COS-7 (kidney, SV40 transformed, African green kidney), HEK-293 (human embryonic kidney), and C6 glioma cells as well as others (Table 1) . Dopamine receptors were expressed individually or in combination in cultured cells in order to study the effect of receptor stimulation on second messenger systems or cellular physiology (Table 2) .
Dopamine-1 Receptors
Transfected D1 like dopamine receptors have been shown to stimulate adenylyl cyclase in a manner similar to that demonstrated in naturally occurring D1 like dopamine receptors. The D1 like dopamine receptor was cloned using polymerase chain reaction with degenerate primers followed by expression in COS-7 cells (3-5). Adenylyl cyclase stimulation by dopamine was found to be dose responsive with an affinity in the micromolar range. Sunahara et al. used similar PCR technique to isolate another member of the human D1 family which demonstrated a strong homology to the D1 dopamine receptors previously cloned and expressed in COS-7 cells, however, it was found to have a 10-fold higher affinity for dopamine. This novel receptor has been designated the D5 (the rat homolog is designated the D1B) dopamine receptor (6).
Rat and human D1A receptors that are expressed in HEK-293, COS-7, and LTK-cells stimulate adenylyl cyclase activity. In LTK-cells in vitro both adenylyl cyclase and phosphoinositide hydrolysis are stimulated. It is not clear if the D1A is linked to both the stimulation of adenylyl cyclase and phosphoinositide hydrolysis or whether there is a novel Gq linked dopamine receptor. Attempts by several investigators have failed to clone a novel D1 like dopamine receptor.
Transfection studies have also helped elucidate the mechanisms by which dopamine receptors mediate other cellular activities beyond the second messenger. We have previously studied the role of the D1A receptor on Na /K ATPase activity in the transfected LTK-cell. We determined one mecha-nism by which D1A receptors inhibit Na+/K+ ATPase activity. In this study, LTK~ cells transfected with the rat D1A cDNA demonstrated that fenoldopam (D1 agonist), stimulated adenylyl cyclase activity and inhibited Na /K ATPase activity (7). This inhibition was mediated via protein kinase A since the protein kinase inhibitor amide completely blocked the D 1 agonist and 8-CPT-cAMP (CAMP analogue) inhibition of Na+ K ATPase activity.
Transfected cells often express receptors to a greater density than encountered in vivo. Therefore, we compared dopamine receptor density (Bmax) and affinity (Kd) and coupling to second messengers in rat striatum, kidney and in our LTKcells (Table 3 ). In our studies D1 like receptors were expressed to a three fold higher density in rat striatum when compared to rat proximal convoluted tubules. The DSA receptor density in D1A transfected cells was only one half that of the striatum. Table 3 also lists densities and affinities for D1 like receptors in the cortical collecting duct (CCD) as well as the brush border membranes (BBM) and basolateral membranes (BLM) from dog kidney. Co-expression of the D1A and the D2L dopamine receptors resulted in a decrease in D1A receptor density but no significant change in receptor affinity. Receptor transfection studies have also elucidated other D2 mediated mechanisms. Felder et al. demonstrated that D2 receptors transfected into COS cells augments the release of arachidonic acid which had been previously stimulated by ATP. The D2 receptor in these cells inhibited cAMP accumulation, however, the effect on arachidonic acid release was determined to be cAMP independent (9). Furthermore, the use of transfected cells have +demons-trated that the D 2 receptor stimulates Na /H exchange activity (10).
Since the renal tubule expresses at least 2 members of the D2 receptor family (D2L, D3), it is of interest to determine the specific physiologic consequence of selective receptor stimulation. Pharmacologic agents have not been developed which are selective for the D2 or D3 receptor family, therefore, we used transfected cells to study the results of selective D2L receptor stimulation.
A murine fibroblast LTK-cell line was created with a rat D2L receptor cDNA. The resulting construct was transfected by a modified calcium phosphate method. Transfected cells were grown in a medium containing G418 sulfate and were selected by positive radioligand binding (Table 4) .
Both transfected and non-transfected LTK-cells were treated by addition of 10 mM butyrate to the medium which markedly enhanced the expression of the D2 receptor and generally increased Na /KATPase activity by 10-20 % in LTK-cells (data not shown). LTK-cell membranes were prepared for ligand binding experiments using [ I] iodospiperone. CyclicAMP was measured in LTK-cells in subconfluent cells by radioimmunoassay. Na+/K+-ATPase activity was assessed by measuring ouabain inhabitable Rb uptake. K channels were blocked and [Na]i was clamped in the experiments performed.
[ I] iodospiperone, a selective radioligand dopamine D2 antagonist, demonstrated specific and saturable binding to transfected LTK-cell membranes (Bmax of 0.91 ± 0.26 pmol/mg protein, n = 7; Kd of 2.39 ± 0.79 nM, n = 7). No specific binding was detected in either LTK-cells that had not been transfected with the D2L or D1A transfected cells. The rank order of potency and Ki value of various D2 agonists and antagonists were in agreement with those reported for D2 receptors in brain tissue and other transfected cell lines. The D2 agonist LY-171555 inhibited forskolin(FSK)-stimulated cAMP production. There was no effect on non-transfected LTK-cells (data not shown).
In the D2L transfected cell, LY caused a concentration-dependent stimulation of Na /K ATPase activity, with maximal stimulation at 1 pM (25 ± 5%, n = 6) which was blocked by 1 pM ( -)-sulpride (D2 selective antagonist). When K channels were blocked by CsCI and [Na]i was clamped by monensin, LY still stimulated Na /K ATPase activity in dose-dependent manner in the D2L transfected cells. To examine whether LY stimulated Na+ IK+ ATPase activity is related to Gi protein, we pre-incubated D2L transfected cells with pertussis toxins. Interestingly, D2 agonist stimulation of the sodium pump was significantly blocked by pertussis toxin, suggesting that Gi _ proteins are implicated in the stimulation of Na /K ATPase activity. Moreover, dideoxy-adenosine (an adenylyl cy-,lase inhibitor) stimulated Na /K ATPase activity in the un-transfected LTK-cells.
These observations are in agreement with physiologic studies which have demonstrated that the intrarenal administration of a highly specific D2 receptor agonist, LY-171555 produced significant dosedependent antidiuresis and antinatriuresis.
Dopamine-1/Dopamine-2 Interaction
In the proximal tubule, dopamine inhibits Na+ /K+ Table 4 S22 Hypertens Res Vol. 18, Suppl. I (1995) ATPase activity. However, in this nephron segment, both D1 and D2 _likereceptors are required f or the inhibition of Na /K ATPase activity (11). A similar mechanism has been described for neuronal cells (12). The mechanism for the D1/D2 receptor synergism is poorly understood since our transfection models have demonstrated that occupation of the D1A receptor causes the inhibition of Na /K ATPase activity via PKA, while the D2L receptor stimulates Na+/K+ ATPase activity. There are increasing numbers of studies that describe a molecular basis for D1/D2 receptor synergism. These studies have been facilitated by the use of transfected cells. For example, Piomelli et al. have demonstrated that co-expression of D 1 and D2 receptors in CHO cells results in the potentiation of the D2 mediated (purigenic initiated) increase in arachidonic acid release (13). Expression of D1 receptors alone in CHO cells has no effect on purigenic initiated arachidonic acid release.
We studied the effect of co-expression of D1A and D2L dopamine receptors in LTK-cells on cAMP production. The co-transfected cells demonstrated specific radioligand binding. D2L dopamine receptor density was approximately 4 fold that of the D1A dopamine receptor using identical transfection protocols. Co-transfection of D2L and D1A dopamine receptors did not alter receptor affinity. Agonists and antagonists demonstrated the correct rank order potency at their respective receptors. Fenoldopam significantly stimulated cAMP production in these co-transfected cells. A concentration of LY 171555 that had no measurable effect of cAMP production potentiated the fenoldopam stimulated adenylyl cyclase activity. We conclude that a D2 agonist enhances the D1 stimulation of adenylyl cyclase activity.
In summary, cells transfected with dopamine receptors have provided analytical tools enabling the determination of receptor mediated mechanisms. The use of more complex co-transfected cell models should allow the elucidation of mechanisms associated with receptor-receptor synergism as well as other receptor activity such as sequestration and down regulation.
